Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis-Reference-Cited by-同舟云学术

Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis

Published:2018-12 Issue:6 Volume:49 Page:1077-1089.e5
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Castellanos Jim G.,Woo Viola,Viladomiu Monica,Putzel Gregory,Lima Svetlana,Diehl Gretchen E.,Marderstein Andrew R.,Gandara Jorge,Perez Alexendar R.,Withers David R.,Targan Stephan R.,Shih David Q.,Scherl Ellen J.,Longman Randy S.

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference47 articles.

1. Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation;Ahn;Eur. J. Immunol.,2015

2. Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells;Awasthi;J. Immunol.,2009

3. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease;Bamias;J. Immunol.,2003

4. The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation;Bamias;Curr. Opin. Gastroenterol.,2013

5. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria;Basu;Immunity,2012

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD;Gut;2024-09-11

2. Microbiota and plasticity of antigen-presenting ILC3s: impact on antitumor immune response;Gut Microbes;2024-08-19

3. RIPK3 and caspase-8 interpret cytokine signals to regulate ILC3 survival in the gut;Mucosal Immunology;2024-08

4. Inflammatory bowel disease and breast cancer: A two-sample bidirectional Mendelian randomization study;Medicine;2024-06-07

5. Microbiota and IBD: Current knowledge and future perspectives;DIGEST LIVER DIS;2024